2020-03-16 17:54:28 CORONAVIRUS
Scientists at the Kaiser Permanente Washington Research Institute began the first-stage study of a potential COVID-19 vaccine on volunteer, Jennifer Haller, in Seattle, Monday, March 16.
READ MORE: A clinical trial evaluating a vaccine designed to protect against the new coronavirus began Monday.
The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle.
Public health officials say it will take a year to 18 months to fully validate any potential vaccine.
Testings begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.